Lord, Abbett & Co
TBI

Lord, Abbett & Co’s Trueblue TBI Stock Holding History

Lord, Abbett & Co’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-248,867
Closed -$2.56M – 599
2024
Q2 		$2.56M Sell
248,867
-109,920
-31% -$1.19M 0.01% 499
2024
Q1 		$4.49M Buy
358,787
+1,303
+0.4% +$16.8K 0.01% 485
2023
Q4 		$5.48M Sell
357,484
-4,509
-1% -$63K 0.02% 450
2023
Q3 		$5.31M Sell
361,993
-2,100
-0.6% -$32.7K 0.02% 456
2023
Q2 		$6.45M Buy
364,093
+180,700
+99% +$3.06M 0.02% 454
2023
Q1 		$3.26M Sell
183,393
-230,200
-56% -$4.3M 0.01% 503
2022
Q4 		$8.1M Sell
413,593
-116,400
-22% -$2.36M 0.03% 446
2022
Q3 		$10.1M Hold
529,993
– – 0.04% 405
2022
Q2 		$9.49M Sell
529,993
-25,700
-5% -$603K 0.03% 414
2022
Q1 		$16.1M Sell
555,693
-62,007
-10% -$1.7M 0.04% 392
2021
Q4 		$17.1M Buy
617,700
+110,480
+22% +$3.13M 0.04% 412
2021
Q3 		$13.7M Buy
507,220
+285,500
+129% +$7.64M 0.03% 474
2021
Q2 		$6.23M Buy
+221,720
New +$5.9M 0.02% 596

Other funds holding TBI

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Lord, Abbett & Co's TBI Position: Q3 2024 in Review

Lord, Abbett & Co sold out of Trueblue (TBI) in Q3 2024, closing a stake of 248,867 shares — an estimated $2.56M sold.

Lord, Abbett & Co first reported a position in TBI in Q2 2021 and held it in 13 quarters. The position peaked at $17.1M in Q4 2021. 112 funds tracked by Wall St. Rank hold TBI as of Q3 2024.

  • Lord, Abbett & Co reported no remaining Trueblue position as of Q3 2024 after selling out during the quarter.
  • Lord, Abbett & Co sold 248,867 Trueblue shares in Q3 2024, an estimated $2.56M.
  • Lord, Abbett & Co first reported a position in Trueblue in Q2 2021 and held it in 13 quarters.
  • Lord, Abbett & Co's Trueblue position peaked at $17.1M in Q4 2021.
  • 112 funds tracked by Wall St. Rank held Trueblue as of Q3 2024.

Based on Lord, Abbett & Co's 13F filing for Q3 2024, filed 14 Nov 2024.